Skip to content

Pre-exposure prophylaxis may only offer limited benefit

Vanguard treatment programmes pave the way to scale up

Little difference in child transmission rates between formula feed and breast-plus-AZT

Two new drug classes given to people with HIV for the first time

Pregnant women with CD4 cell counts over 250 not at greater risk of nevirapine-related toxicity in Kenyan study

Therapeutic range for atazanavir defined

Three trials bring African mother to child transmission down to four per cent; WHO vows to reconsider guidelines

MRSA in HIV-positive patients often community acquired, associated with HIV disease severity

Therapeutic drug monitoring useful for improving treatment outcomes in many patients taking HAART